Next Financials Will Set BioMed A Part From The RestThis quarter ends Jan 31. This will be the first quarter to show full recreational sales.
If recent filings have shown us anything, it is that BioMed is very punctual and filing well ahead of due dates.
Recent filings have also shown the demand for BioMeds products and how they are the lowest cost per gram producer out of any LP and can sell top quality products for less than half of competitors.
They have also demonstrated how their business strategy is paying off bigtime with cash purchases of strata lots and keeping very low overhead to gain higher profit margins and keeping low cost high quality products.
We have seen BioMed consistently hold top sales in British Columbia, and have also added Saskatoon retailer to the list of recreational sales.
We have also seen the medical sales take off and consistently sell out and concurrently resupplied within days of depletion demonstrating their ability to keep up with current product demand.
These next financial statements will be the ones to set THC BioMed a part from the rest and will be the catalyst to fire tgis up towards new highs IMO